{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:17:43Z","timestamp":1787026663496,"version":"build-2736575974"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute decompensation (AD) in patients with liver cirrhosis is associated with a dramatic deterioration in prognosis. Immediate initiation of appropriate recompensation measures is essential to improve patient\u2019s outcome, although objective parameters for evaluating the success of recompensation are still lacking. Spleen stiffness measurements (SSM) have emerged as promising non-invasive tool to assess clinically significant portal hypertension (CSPH), which is the main driver of acute decompensation. However, while SSM accurately predicts CSPH and its complication, currently no data are available on its diagnostic performance during recompensation. This pilot-study aimed at evaluating changes in spleen stiffness following the initiation of recompensation measures in cirrhotic patients hospitalized due to AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this prospective pilot-study, 60 patients with cirrhosis showing AD were included. Liver stiffness measurements (LSM) and SSM were performed on admission and repetitive SSM on day 3 and 5, respectivele, during recompensation measures. A cohort of patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910) with compensated cirrhosis served as control.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 36 data sets from the originally enrolled 60 patients were eligible for final analysis. On admission, patients with AD revealed a significantly increased spleen stiffness compared to the control group (70.51 vs. 29.06\u2009kPa,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.0001). Following the initiation of recompensation measures SSM revealed a significant reduction in spleen stiffness compared to the baseline assessment on day 3 (\u221218.5\u2009kPa, \u221221.53%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0002) with no further decrease on day 5 (\u221217.63\u2009kPa, \u221221.23%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0326).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Repetitive SSM seems to be a useful non-invasive clinical marker to assess the effectiveness of recompensation measures in cirrhotic patients with AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2024.1475997","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T23:25:53Z","timestamp":1732490753000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Spleen stiffness measurements during recompensation in patients with acutely decompensated liver cirrhosis: preliminary findings of a pilot study"],"prefix":"10.3389","volume":"11","author":[{"given":"Dilan Elcin","family":"Bozal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hannemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"B\u00fcrger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Allo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Dittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Jaspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Holzapfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hun","family":"Chon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Goeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Michael","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis - aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis","volume":"2","author":"Arroyo","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1268102","DOI":"10.3389\/fmed.2023.1268102","article-title":"Prognostic assessment of liver cirrhosis and its complications: current concepts and future perspectives","volume":"10","author":"G\u00fclcicegi","year":"2023","journal-title":"Front Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2021.06.018","article-title":"Towards a new definition of decompensated cirrhosis","volume":"76","author":"D\u2019Amico","year":"2022","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/HEP.0000000000000652","article-title":"Further decompensation in cirrhosis: results of a large multicenter cohort study supporting Baveno VII statements","volume":"79","author":"D\u2019Amico","year":"2024","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.dld.2022.12.014","article-title":"The Baveno VII concept of cirrhosis recompensation","volume":"55","author":"Reiberger","year":"2023","journal-title":"Dig Liver Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"100316","DOI":"10.1016\/j.jhepr.2021.100316","article-title":"Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy","volume":"3","author":"Iwakiri","year":"2021","journal-title":"JHEP Rep."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S2468-1253(23)00438-7","article-title":"Pathophysiology and therapeutic options for cirrhotic portal hypertension","volume":"9","author":"Guix\u00e9-Muntet","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jhep.2023.04.028","article-title":"TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis","volume":"79","author":"Larrue","year":"2023","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jhep.2023.12.028","article-title":"Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient","volume":"11","author":"Jachs","year":"2024","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/HEP.0000000000000841","article-title":"Non-invasive liver disease assessment to identify portal hypertension: a systematic review supporting the AASLD practice guideline","volume":"15","author":"Rockey","year":"2024","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.cgh.2022.09.032","article-title":"The sequential application of Baveno VII criteria and VITRO score improves diagnosis of clinically significant portal hypertension","volume":"21","author":"Jachs","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/HEP.0000000000000618","article-title":"Noninvasive assessment of hepatic decompensation","volume":"6","author":"Thiele","year":"2023","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2468-1253(23)00150-4","article-title":"Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis","volume":"8","author":"Dajti","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jceh.2022.12.015","article-title":"Spleen stiffness measurement across the Spectrum of liver disease patients in real-world practice","volume":"13","author":"Lantinga","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/hep4.1855","article-title":"The value of liver and spleen stiffness for evaluation of portal hypertension in compensated cirrhosis","volume":"6","author":"Reiberger","year":"2022","journal-title":"Hepatol Commun"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jhep.2014.02.024","article-title":"Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study","volume":"60","author":"Colecchia","year":"2014","journal-title":"J Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jhep.2018.10.018","article-title":"Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices","volume":"70","author":"Kim","year":"2019","journal-title":"J Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jhep.2018.04.023","article-title":"A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease","volume":"69","author":"Colecchia","year":"2018","journal-title":"J Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s12072-020-10062-w","article-title":"Spleen stiffness measurement for assessing the response to \u03b2-blockers therapy for high-risk esophageal varices patients","volume":"14","author":"Marasco","year":"2020","journal-title":"Hepatol Int"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"100952","DOI":"10.1016\/j.jhepr.2023.100952","article-title":"Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis","volume":"6","author":"Rigamonti","year":"2024","journal-title":"JHEP Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF consortium acute decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/cld.1185","article-title":"A primer to the diagnostic and clinical utility of spleen stiffness measurement in patients with chronic liver disease","volume":"19","author":"Mladenovic","year":"2022","journal-title":"Clin Liver Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.dld.2017.09.138","article-title":"Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation","volume":"50","author":"Buechter","year":"2018","journal-title":"Dig Liver Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII-renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"13674","DOI":"10.1038\/s41598-024-63848-5","article-title":"Enhancing liver cirrhosis varices and CSPH risk prediction with spleen stiffness measurement using 100-Hz probe","volume":"14","author":"Yoo","year":"2024","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/MOG.0000000000001019","article-title":"Noninvasive assessment of liver fibrosis and portal hypertension","volume":"40","author":"Duarte-Rojo","year":"2024","journal-title":"Curr Opin Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/MCG.0000000000001044","article-title":"Spleen stiffness differentiates between acute and chronic liver damage and predicts hepatic decompensation","volume":"53","author":"Meister","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1016\/S0168-8278(24)00924-3","article-title":"SAT-078-YI prospective 5-year follow-up study of spleen stiffness measurement with a spleen-dedicated module (SSM@100 Hz) for predicting hepatic decompensation in cACLD: competitive risk analysis","volume":"80","author":"Colecchia","year":"2024","journal-title":"J Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S2468-1253(24)00234-6","article-title":"Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study","volume":"23","author":"Jachs","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","article-title":"Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis","volume":"144","author":"Berzigotti","year":"2013","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cld.2021.01.005","article-title":"Noninvasive detection of clinically significant portal hypertension in compensated advanced chronic liver disease","volume":"25","author":"Vuille-Lessard","year":"2021","journal-title":"Clin Liver Dis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jhep.2019.02.012","article-title":"Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease","volume":"70","author":"Hammoutene","year":"2019","journal-title":"J Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"11904","DOI":"10.3390\/ijms241511904","article-title":"Proteomic analysis of dysfunctional liver sinusoidal endothelial cells reveals substantial differences in most common experimental models of chronic liver diseases","volume":"24","author":"Gil","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3390\/ijms17091545","article-title":"Correlations of hepatic hemodynamics, liver function, and fibrosis markers in nonalcoholic fatty liver disease: comparison with chronic hepatitis related to hepatitis C virus","volume":"17","author":"Shigefuku","year":"2016","journal-title":"Int J Mol Sci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e174775","DOI":"10.1172\/jci.insight.174775","article-title":"Liver sinusoidal endothelial cells contribute to portal hypertension through collagen type IV-driven sinusoidal remodeling","volume":"9","author":"Gan","year":"2024","journal-title":"JCI Insight"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/pin.13361","article-title":"Endotheliopathy of liver sinusoidal endothelial cells in liver disease","volume":"73","author":"Kondo","year":"2023","journal-title":"Pathol Int"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jhep.2024.05.014","article-title":"Angiocrine signaling in sinusoidal homeostasis and liver diseases","volume":"81","author":"Gao","year":"2024","journal-title":"J Hepatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.7150\/ijms.17738","article-title":"Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis","volume":"14","author":"Maruyama","year":"2017","journal-title":"Int J Med Sci"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3748\/wjg.14.795","article-title":"Portalsystemic hemodynamic changes in chronic severe hepatitis B: an ultrasonographic study","volume":"14","author":"Su","year":"2008","journal-title":"World J Gastroenterol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1111\/j.1530-0277.2008.00755.x","article-title":"Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis-comparison with liver cirrhosis related to hepatitis C virus and nonalcoholic steatohepatitis","volume":"34","author":"Takahashi","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12964-024-01720-9","article-title":"Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease","volume":"22","author":"He","year":"2024","journal-title":"Cell Commun Signal"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality","volume":"74","author":"Costa","year":"2021","journal-title":"J Hepatol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Cl\u00e0ria","year":"2016","journal-title":"Hepatology"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/ije\/dyh299","article-title":"Regression to the mean: what it is and how to deal with it","volume":"34","author":"Barnett","year":"2004","journal-title":"Int J Epidemiol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1475997\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:20:22Z","timestamp":1784114422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1475997\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":51,"alternative-id":["10.3389\/fmed.2024.1475997"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1475997","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"article-number":"1475997"}}